Barcelona

• Phase Ib/II trial of the combination of atezolizumab with dendritic cell vaccination as maintenance treatment in patients with extensive sta … Ended
  2024-518636-36-00 8 2024-10-10 Lung Cancer
• A trial to learn if AZD9829 is safe and works alone and in combination with other treatments for participants with certain blood cancers. Ended
  2023-506997-11-00 1 2024-10-09 CD123-Positive Hematological Malignancies: Module 1 focuses on R/R Acu
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Do … Ended
  2023-504426-19-00 1 2024-10-01 Pulmonary fibrosis
• A Study of HST-1011 For The Treatment Of People With Advanced Cancers That Are Not Benefiting From Other Standard of Care Therapies Ended
  2023-503731-18-00 7 2024-09-30 Advanced Solid Tumors
• Vonafexor fixed dose-escalation safety and proof-of-concept study in patients with at risk of progression Alport syndrome Ended
  2023-509638-20-00 4 2024-09-30 Alport Syndrome
• A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB … Ended
  2023-507376-50-00 1 2024-09-27 Ulcerative Colitis
• Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos … Ended
  2023-506000-50-00 4 2024-09-26 Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-H
• A trial to learn how AZD4604 acts in the body and how safe it is in adults with asthma Ended
  2023-510291-32-00 4 2024-09-26 Asthma
• An open label, multicenter, phase II study of belantamab mafodotin in combination with VRd for the treatment of newly diagnosed transplant e … Ended
  2024-516130-35-00 4 2024-09-26 Multiple myeloma
• Phase 2 study to evaluate the efficacy and safety of GSK3915393 in participants with Idiopathic Pulmonary Fibrosis (IPF) Ended
  2023-509371-16-00 4 2024-09-25 Idiopathic Pulmonary Fibrosis
• A phase 2b dose finding study of RMC-035 in participants undergoing open-chest cardiac surgery Ended
  2024-510658-28-00 4 2024-09-24 Loss of renal function following cardiac surgery
• A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe … Ended
  2024-511363-28-00 5 2024-09-24 hidradenitis suppurativa (HS)
• A first-in-human study to learn how safe the study treatment BAY2862789 is, to find the best dose, how it affects the body, what maximum amo … Ended
  2024-510998-26-00 1 2024-09-18 Advanced solid tumors
• A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in adult participants with severe … Ended
  2024-511225-64-00 4 2024-09-18 Alopecia areata
• A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended
  2023-505797-15-00 5 2024-09-13 SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
• A Phase 1/2 Study of AMG 193 in Combination with IDE397 in Subjects with Advanced MTAP-null Solid Tumors Ended
  2023-504364-42-00 9 2024-09-12 In Part 1, subjects with advanced MTAP-null solid tumors and, in Part
• A safety study of PF-08046044/SGN-35C in adults with advanced cancers Ended
  2023-505813-26-00 1 2024-09-12 Lymphoma, Large B-Cell, Diffuse
• A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended
  2023-508395-11-00 4 2024-09-10 idiopathic pulmonary fibrosis
• A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended
  2023-510249-79-00 4 2024-09-10 Progressive pulmonary fibrosis (PPF)
• The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. Ended
  2024-514322-23-00 6 2024-09-09 infertility
• A Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy Ended
  2023-508465-32-00 5 2024-09-03 Narcolepsy with Cataplexy (Narcolepsy Type 1)
• Safety and Efficacy of NMD670 in Adult Patients with Type 1 and Type 2 Charcot-Marie-Tooth Disease Ended
  2023-507892-23-00 4 2024-08-30 Charcot-Marie-Tooth Disease Type 1 and Type 2
• Phase Ib Clinical Trial to Evaluate the Safety Profile of the Combination Tilray FS Oral Solution T10:C10 with Temozolomide and Radiotherapy … Ended
  2024-515546-16-00 3 2024-08-27 Glioblastoma
• MK-0616 versus Comparators Study in Adults with Hypercholesterolemia Ended
  2023-504920-25-00 5 2024-08-23 Hypercholesterolemia

Showing 2,617–2,640 of 3,391 trials